Mfsd8-KO Mouse
Common Name
Mfsd8-KO
제품 ID
S-KO-16646
Backgroud
C57BL/6JCya
품종 계통계통 ID
KOCMP-72175-Mfsd8-B6J-VB
상태
이 마우스 계통을 논문에서 사용할 경우, “Mfsd8-KO Mouse (카탈로그 번호 S-KO-16646)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
기본 정보
품종 계통
Mfsd8-KO
품종 계통계통 ID
KOCMP-72175-Mfsd8-B6J-VB
유전자명
제품 ID
S-KO-16646
유전자 별칭
Cln7, 2810423E13Rik
배경
C57BL/6JCya
NCBI ID
변형 내용
Conventional knockout
염색체
Chr 3
Phenotype
Datasheet
적용 분야
--
품종 계통 설명
Ensembl 전사체 ID
ENSMUST00000026859
NCBI 전사체 ID
NM_028140
타겟 영역
Exon 2
유효 영역 크기
~0.6 kb
유전자 연구 개요
MFSD8, also known as CLN7, is a transmembrane protein reported to function as a lysosomal chloride channel [2]. It has been associated with the regulation of conserved processes during the life cycle of the social amoeba Dictyostelium discoideum [2]. In humans, it is involved in neuronal ceroid lipofuscinosis (NCL) diseases, highlighting its importance in human health [2,3,5,7,9]. Genetic models like Dictyostelium discoideum help in studying its functions [2,5,7].
Mutations in MFSD8 can cause type 7 neuronal ceroid lipofuscinosis, leading to vision loss and other systemic symptoms [1]. It can also cause isolated retinal dystrophy or non-syndromic macular dystrophy without systemic signs [1,3,8]. In Dictyostelium, loss of mfsd8 deregulates protein secretion, affects proteasome activity, and impacts the organism's development, including growth, pinocytosis, and aggregation [2,5]. In Mfsd8-/-mice, AAV9/MFSD8 gene therapy shows age-and dose-dependent effects, improving various disease-related phenotypes [4]. In a CLN7-deficient HEK293T cell line, the viral load of SARS-CoV-2 is reduced, indicating MFSD8's potential role in the virus's cell entry [6].
In summary, MFSD8 is crucial for normal physiological functions, especially related to lysosomal function, protein secretion, and cell-related processes. Model-based research, such as in Dictyostelium and Mfsd8-/-mice, has revealed its role in diseases like neuronal ceroid lipofuscinosis, retinal dystrophies, and potentially in SARS-CoV-2 infection. Understanding MFSD8 provides insights into disease mechanisms and potential therapeutic targets for these associated diseases.
References:
1. Priluck, Aaron Z, Breazzano, Mark P. 2022. Novel MFSD8 mutation causing non-syndromic asymmetric adult-onset macular dystrophy. In Ophthalmic genetics, 44, 186-190. doi:10.1080/13816810.2022.2092758. https://pubmed.ncbi.nlm.nih.gov/35801630/
2. Huber, Robert J, Gray, Joshua, Kim, William D. 2023. Loss of mfsd8 alters the secretome during Dictyostelium aggregation. In European journal of cell biology, 102, 151361. doi:10.1016/j.ejcb.2023.151361. https://pubmed.ncbi.nlm.nih.gov/37742391/
3. Zare-Abdollahi, Davood, Bushehri, Ata, Alavi, Afagh, Jamali, Payman, Khorram Khorshid, Hamid Reza. 2019. MFSD8 gene mutations; evidence for phenotypic heterogeneity. In Ophthalmic genetics, 40, 141-145. doi:10.1080/13816810.2019.1592200. https://pubmed.ncbi.nlm.nih.gov/31006324/
4. Chen, Xin, Dong, Thomas, Hu, Yuhui, Mazzulli, Joseph R, Gray, Steven J. . AAV9/MFSD8 gene therapy is effective in preclinical models of neuronal ceroid lipofuscinosis type 7 disease. In The Journal of clinical investigation, 132, . doi:10.1172/JCI146286. https://pubmed.ncbi.nlm.nih.gov/35025759/
5. Yap, Shyong Quan, Kim, William D, Huber, Robert J. 2022. Mfsd8 Modulates Growth and the Early Stages of Multicellular Development in Dictyostelium discoideum. In Frontiers in cell and developmental biology, 10, 930235. doi:10.3389/fcell.2022.930235. https://pubmed.ncbi.nlm.nih.gov/35756993/
6. Heinl, Elena-Sofia, Lorenz, Sebastian, Schmidt, Barbara, Wetzel, Christian H, Reichold, Markus. 2022. CLN7/MFSD8 may be an important factor for SARS-CoV-2 cell entry. In iScience, 25, 105082. doi:10.1016/j.isci.2022.105082. https://pubmed.ncbi.nlm.nih.gov/36093380/
7. Huber, Robert J, Mathavarajah, Sabateeshan, Yap, Shyong Quan. 2020. Mfsd8 localizes to endocytic compartments and influences the secretion of Cln5 and cathepsin D in Dictyostelium. In Cellular signalling, 70, 109572. doi:10.1016/j.cellsig.2020.109572. https://pubmed.ncbi.nlm.nih.gov/32087303/
8. Xiang, Qin, Cao, Yanna, Xu, Hongbo, Deng, Hao, Yuan, Lamei. 2021. Novel MFSD8 Variants in a Chinese Family with Nonsyndromic Macular Dystrophy. In Journal of ophthalmology, 2021, 6684045. doi:10.1155/2021/6684045. https://pubmed.ncbi.nlm.nih.gov/34457359/
9. Qiao, Yimeng, Gu, Yang, Cheng, Ye, Shang, Qing, Xing, Qinghe. 2022. Case Report: Novel MFSD8 Variants in a Chinese Family With Neuronal Ceroid Lipofuscinoses 7. In Frontiers in genetics, 13, 807515. doi:10.3389/fgene.2022.807515. https://pubmed.ncbi.nlm.nih.gov/35154277/
품질 관리 기준
정자 검사
동결 보존 전: 정자 농도 측정 및 정자 생존율 평가.
동결 보존 후: 각 배치에서 동결 보존된 정자 바이알 1개를 선택하여 체외수정(in vitro fertilization)에 사용합니다.
Environmental Standards:
SPFAvailable Region:
GlobalSource:
Cyagen문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.
